Biotech

All Articles

Biogen containers SAGE-324 partnership after vital trembling stop working

.Biogen has administered the final rites to its own partnership along with Sage Therapeutics on SAGE...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase scores

.On the very same time that some Parkinson's disease medications are being cast doubt on, AbbVie has...

Arch finalizes $3B-plus fund to promote biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Financing Life Sciences, Arc Project Partners is...

Orion to make use of Aitia's 'electronic doubles' to find new cancer medicines

.Finnish biotech Orion has spied prospective in Aitia's "electronic identical twin" specialist to bu...

Windtree's surprise med brings up blood pressure in most current stage 2 succeed

.While Windtree Therapies has actually struggled to expand the financial roots needed to endure, a s...

2 cancer biotechs merge, making worldwide footprint

.OncoC4 is taking AcroImmune-- and also its own internal professional manufacturing capacities-- und...

Amgen documents 1st period 3 win for $400M chronic eczema drug

.Amgen has shared (PDF) the very first stage 3 data on its $400 million dermatitis drug, connecting ...

Biogen, UCB record stage 3 lupus gain after stopping working earlier test

.Biogen and UCB's bet one's bottom dollar improving right into phase 3 astride an unsuccessful resea...

Aptadir hopes new RNA preventions may turn around tricky cancers

.Italian biotech Aptadir Therapies has actually introduced with the assurance that its own pipe of p...

Wave surfs DMD effectiveness to regulators' doors, delivering stock up

.Surge Life Sciences has actually met its own goal in a Duchenne muscle dystrophy (DMD) study, placi...